Dabietes mallotus

The user likely means Diabetes mellitus - let me look that up from the medical library.
Searching sources...
Reading File
Finding Sources
Searching the Web

diabetes mellitus overview types classification pathophysiology 2025

Reading File
Finding Sources
Reading File
Reading File
Reading File
Now I have enough information from the textbooks to give a thorough answer. Let me compile everything.

Diabetes Mellitus

(Note: "Dabietes mallotus" is interpreted as Diabetes Mellitus - a common spelling variation.)

Definition

Diabetes mellitus (DM) is a metabolic disease characterized by elevated blood glucose (hyperglycemia) resulting from absent or inadequate pancreatic insulin secretion, with or without concurrent impairment of insulin action. - Katzung's Basic and Clinical Pharmacology, 16e

Classification (ADA - 4 Types)

The American Diabetes Association (ADA) classifies DM into four clinical types:
TypeMechanism
Type 1 DM (T1DM)Autoimmune beta-cell destruction → absolute insulin deficiency
Type 2 DM (T2DM)Progressive loss of beta-cell insulin secretion + insulin resistance
Gestational DM (GDM)Diabetes first diagnosed during pregnancy, not pre-existing
Other specific typesMonogenic (MODY, neonatal), pancreatic disease, drug-induced (steroids, antiretrovirals), post-transplant
  • Creasy & Resnik's Maternal-Fetal Medicine, Katzung's Basic and Clinical Pharmacology

Type 1 Diabetes Mellitus

  • Mechanism: Selective autoimmune beta-cell destruction in the islets of Langerhans leading to severe or absolute insulin deficiency
  • Subtypes: Type 1a (immune-mediated) and Type 1b (idiopathic)
  • Age: Most often <30 years, but can occur at any age
  • Autoantibodies present at diagnosis:
    • Anti-GAD65 (glutamic acid decarboxylase)
    • Insulin autoantibody (IAA)
    • Anti-IA2 (tyrosine phosphatase)
    • Anti-ZnT8 (zinc transporter 8)
  • Genetics: >60 genetic loci identified; highest incidence in Northern Europeans and Sardinians
  • Treatment: Parenteral insulin is essential to sustain life and prevent diabetic ketoacidosis (DKA)
  • LADA: Up to 10-15% of apparent "type 2" patients in Northern Europeans actually have latent autoimmune diabetes of adulthood (LADA), a slow-onset form of T1DM
A notable recent advance: Teplizumab (anti-CD3 monoclonal antibody) is now approved for high-risk Stage 2 T1DM patients (age ≥8) to delay onset of overt T1DM by ~25 months.
  • Katzung's Basic and Clinical Pharmacology, 16e

Type 2 Diabetes Mellitus

  • Mechanism: Tissue insulin resistance + relative insulin secretory deficiency
  • Endogenous insulin is enough to prevent ketoacidosis, but not enough to prevent hyperglycemia
  • A patient may have predominantly resistance or predominantly secretory failure
  • Initial management: Diet, exercise, and oral/injectable non-insulin agents
  • Later stages: Progressive beta-cell failure may eventually require insulin therapy
  • Katzung's Basic and Clinical Pharmacology, 16e

Diagnosis (Non-Pregnant Adults)

Any ONE of the following criteria:
  • Fasting plasma glucose ≥ 126 mg/dL (after ≥8 hours fasting)
  • 2-hour plasma glucose ≥ 200 mg/dL during 75g OGTT
  • HbA1c ≥ 6.5%
  • Random plasma glucose ≥ 200 mg/dL in a symptomatic patient

Complications

CategoryExamples
MicrovascularDiabetic nephropathy, retinopathy, neuropathy
MacrovascularCoronary artery disease, stroke, peripheral arterial disease
Acute metabolicDKA (Type 1), Hyperosmolar hyperglycemic state (Type 2), hypoglycemia

Key Treatments Summary

Type 1: Insulin (basal-bolus regimen)
Type 2 (selected drugs):
  • Metformin (first-line)
  • GLP-1 receptor agonists (e.g., semaglutide)
  • SGLT-2 inhibitors (e.g., empagliflozin)
  • DPP-4 inhibitors (e.g., sitagliptin)
  • Insulin (when needed)
Insulin types available:
  • Rapid-acting: Lispro, Aspart, Glulisine
  • Short-acting: Regular insulin
  • Long-acting (basal): Glargine, Detemir, Degludec
  • Katzung's Basic and Clinical Pharmacology, 16e

For current ADA guidelines, the 2025 ADA Standards of Care are the most up-to-date reference.
This is a shared conversation. Sign in to Orris to start your own chat.